Back to the Top
Hi all,
Our project is focused on the reversal of multidrug resistance using the
chemosensitizer, PSC 833 and liposome-encapsulated doxorubicin. In order
to determine how the anticancer drug is localized within tumor tissue, we
plan to investigate the subcellular localization using confocal
mircoscopy. However, it is likely that the sample handling procedures
used routinely for CFM will disrupt the membrane causing drug release from
liposome and eventual binding to DNA. Are there non-invasive imaging
techniques that could be used to determine accurate subcellular
localization of the anticancer drug in tumor tissues and liver? Any
thoughts on this is much appreciated and welcome.
Rajesh Krishna
BC Cancer Agency
Vancouver, BC
Editor, Liposome Drug Delivery Systems Home Page
http://members.tripod.com/~rkrishna/
Back to the Top
Dear Dr Krishna:
Is there any way you can radio label your delivery system? That woud be
one way, as long as the radiolabelling doesn't change the pharmacokinetics
or dynamics of the drug.
Let me know if this helps!
Michael Silver
Bio-Imaigng Technologies, Inc
Mahwah NJ
201 760 9510
FAX 201 327 2106
PharmPK Discussion List Archive Index page
Copyright 1995-2010 David W. A. Bourne (david@boomer.org)